Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer [Phase 1]
A Phase 1 clinical trial evaluating the targeted alpha therapy At-211 PSMA-5 for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Prostate Cancer Study of Patient Experiences
This clinical trial update notes a not-yet-recruiting study at Ankara University examining patient experiences related to prostate cancer.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse [Phase 3]
This entry describes a Phase III clinical trial evaluating cabazitaxel with pelvic radiotherapy for localized prostate cancer and high-risk …
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy [Phase 3]
A Phase 3 study is evaluating apalutamide with radiotherapy and an LHRH agonist in prostate cancer patients after prostatectomy, and is curr…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound [NA]
A clinical trial comparing single-port transvesical partial prostatectomy versus high-intensity focused ultrasound for prostate cancer is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer [Phase 3]
Phase 3 study update for ProstAtak immunotherapy with standard radiation therapy in localized prostate cancer; trial is currently active but…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) [Phase 2]
Phase 2 randomized trial evaluating CAN-2409 immunotherapy during active surveillance for prostate cancer (ULYSSES) is currently active but …
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial
This clinical trial update reports that the PROSTAR trial evaluating stereotactic body radiation therapy with androgen deprivation therapy f…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating safety and tolerability of NOX66 in combination with palliative radiotherapy in men with late-stage prosta…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy [Phase 4]
A Phase 4 clinical trial is investigating GLP-1 receptor agonists in men with prostate cancer who are receiving androgen deprivation therapy…
-
EMA approval · 2025-07-28EMA Authorised: Xofigo (radium (223Ra) dichloride) — Bayer AG
The EMA authorised Xofigo (radium-223 dichloride) for prostate cancer with Bayer AG as the marketing authorisation holder; decision date 28 …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) [NA]
Clinical trial update on PSMA MRI-guided prostate SBRT with longitudinal imaging biomarker assessments after radiotherapy in prostate cancer…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Jump: MR Simulation For Radiation Therapy Master Protocol [NA]
Clinical trial update for the Jump: MR Simulation For Radiation Therapy Master Protocol, sponsored by Brigham and Women's Hospital, currentl…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
This clinical trial update describes the PROFILE study, which investigates whether germline genetic profiling can inform targeted prostate c…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
This clinical trial is evaluating postoperative stereotactic body radiotherapy with adaptive technology to minimize toxicity in prostate can…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP） [NA]
A clinical trial is evaluating an AI-LLM communication aid to support prostate cancer care. The study is sponsored by Fudan University and i…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Prostate Cancer Care Disparity Analysis Project (ProGAP)
An ongoing clinical trial at Ankara University focusing on disparities in prostate cancer care (ProGAP); recruitment is currently ongoing.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer [NA]
A clinical trial update indicates that the Imperial Prostate 7 study is currently recruiting to evaluate fast MRI and image-fusion technique…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate [Phase 3]
Phase 3 study evaluating 6-month subcutaneous triptorelin in adult men with prostate cancer. The trial results have been posted.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging [Phase 2]
A Phase 2 clinical trial evaluating the utility of hyperpolarized 13C-pyruvate metabolic MRI for prostate cancer, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)
The ASPIRE study investigates active surveillance in prostate cancer. It uses imaging to detect radiographic progression as an endpoint.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging [Phase 2]
A Phase 2 clinical trial comparing 68Ga-RM2 PET/CT to 68Ga-PSMA-617 PET/CT for imaging in intermediate-risk prostate cancer has been complet…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy [Phase 2]
A Phase 2 clinical trial update evaluating whether a human amnion membrane allograft can promote early return of erectile function after rad…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer [NA]
This ClinicalTrials.gov entry notes that TRUEBEAM Stereotactic Body Radiotherapy is being studied for localized prostate cancer and is curre…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) [NA]
A UCSF-sponsored clinical trial called 'Tools To Be Fit' aims to improve nutrition and physical activity among cancer survivors and is curre…